A new drug cocktail is four times more effective at keeping Covid patients out of intensive care, initial tests have suggested. While the steroid dexamethasone was the first drug to be licensed for treating the virus, trials indicate that combining it with heart failure medication spironolactone yields better results. ...The treatment works by ‘turning off’ the impact the virus has on the body, rather than targeting the virus itself.